Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Critical Pharmaceuticals Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone
Feb. 13, 2013
Critical Pharmaceuticals today announced that it has successfully completed a second clinical study on its CP024 growth hormone nasal spray.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing